Selected research
Market Analysis & Forecast
Global Long-Read Sequencing Services Market Analysis and Forecast 2026-2032
Market perspective
The global Long-Read Sequencing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Long-Read Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Long-Read Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Long-Read Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Long-Read Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Long-Read Sequencing Services include Oxford Nanopore, Agilent Technologies, Thermo Fisher Scientific, QIAGEN, PacBio, Illumina, Takara Bio, 10X Genomics and Danaher, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Long-Read Sequencing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Long-Read Sequencing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Long-Read Sequencing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Long-Read Sequencing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long-Read Sequencing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Long-Read Sequencing Services revenue, projected growth trends, production technology, application and end-user industry.
Long-Read Sequencing Services Segment by Company
Oxford Nanopore
Agilent Technologies
Thermo Fisher Scientific
QIAGEN
PacBio
Illumina
Takara Bio
10X Genomics
Danaher
Azenta US
Revvity
New England Biolabs
BaseClear
Element Biosciences
CD Genomics
Sage Sciences
EdenRoc Sciences
Genewiz
BGI Group
Novogene
Grandomics
Wuhan Beina Technology
Long-Read Sequencing Services Segment by Type
Nanopore Sequencing
Single-molecule Real-time Sequencing
Synthetic Long-read Sequencing
Long-Read Sequencing Services Segment by Application
Research Institutes
Hospitals
Pharmaceutical
Others
Long-Read Sequencing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Read Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Long-Read Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Read Sequencing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Long-Read Sequencing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Long-Read Sequencing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-Read Sequencing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nanopore Sequencing
- Single-molecule Real-time Sequencing
- Synthetic Long-read Sequencing
Applications
- Research Institutes
- Hospitals
- Pharmaceutical
- Others
Companies covered
- Oxford Nanopore
- Agilent Technologies
- Thermo Fisher Scientific
- QIAGEN
- PacBio
- Illumina
- Takara Bio
- 10X Genomics
- Danaher
- Azenta US
- Revvity
- New England Biolabs
- BaseClear
- Element Biosciences
- CD Genomics
- Sage Sciences
- EdenRoc Sciences
- Genewiz
- BGI Group
- Novogene
- Grandomics
- Wuhan Beina Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Long-Read Sequencing Services Market by Type
- 1.2.1 Global Long-Read Sequencing Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Nanopore Sequencing
- 1.2.3 Single-molecule Real-time Sequencing
- 1.2.4 Synthetic Long-read Sequencing
- 1.3 Long-Read Sequencing Services Market by Application
- 1.3.1 Global Long-Read Sequencing Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Research Institutes
- 1.3.3 Hospitals
- 1.3.4 Pharmaceutical
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Long-Read Sequencing Services Market Dynamics
- 2.1 Long-Read Sequencing Services Industry Trends
- 2.2 Long-Read Sequencing Services Industry Drivers
- 2.3 Long-Read Sequencing Services Industry Opportunities and Challenges
- 2.4 Long-Read Sequencing Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Long-Read Sequencing Services Market Perspective (2021-2032)
- 3.2 Global Long-Read Sequencing Services Growth Trends by Region
- 3.2.1 Global Long-Read Sequencing Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Long-Read Sequencing Services Market Size by Region (2021-2026)
- 3.2.3 Global Long-Read Sequencing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Long-Read Sequencing Services Revenue by Players
- 4.1.1 Global Long-Read Sequencing Services Revenue by Players (2021-2026)
- 4.1.2 Global Long-Read Sequencing Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Long-Read Sequencing Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Long-Read Sequencing Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Long-Read Sequencing Services Key Players Headquarters & Area Served
- 4.4 Global Long-Read Sequencing Services Players, Product Type & Application
- 4.5 Global Long-Read Sequencing Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Long-Read Sequencing Services Market CR5 and HHI
- 4.6.3 2025 Long-Read Sequencing Services Tier 1, Tier 2, and Tier 3
5 Long-Read Sequencing Services Market Size by Type
- 5.1 Global Long-Read Sequencing Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Long-Read Sequencing Services Revenue by Type (2021-2032)
- 5.3 Global Long-Read Sequencing Services Revenue Market Share by Type (2021-2032)
6 Long-Read Sequencing Services Market Size by Application
- 6.1 Global Long-Read Sequencing Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Long-Read Sequencing Services Revenue by Application (2021-2032)
- 6.3 Global Long-Read Sequencing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Oxford Nanopore
- 7.1.1 Oxford Nanopore Company Information
- 7.1.2 Oxford Nanopore Business Overview
- 7.1.3 Oxford Nanopore Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Oxford Nanopore Long-Read Sequencing Services Product Portfolio
- 7.1.5 Oxford Nanopore Recent Developments
- 7.2 Agilent Technologies
- 7.2.1 Agilent Technologies Company Information
- 7.2.2 Agilent Technologies Business Overview
- 7.2.3 Agilent Technologies Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.2.4 Agilent Technologies Long-Read Sequencing Services Product Portfolio
- 7.2.5 Agilent Technologies Recent Developments
- 7.3 Thermo Fisher Scientific
- 7.3.1 Thermo Fisher Scientific Company Information
- 7.3.2 Thermo Fisher Scientific Business Overview
- 7.3.3 Thermo Fisher Scientific Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Thermo Fisher Scientific Long-Read Sequencing Services Product Portfolio
- 7.3.5 Thermo Fisher Scientific Recent Developments
- 7.4 QIAGEN
- 7.4.1 QIAGEN Company Information
- 7.4.2 QIAGEN Business Overview
- 7.4.3 QIAGEN Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.4.4 QIAGEN Long-Read Sequencing Services Product Portfolio
- 7.4.5 QIAGEN Recent Developments
- 7.5 PacBio
- 7.5.1 PacBio Company Information
- 7.5.2 PacBio Business Overview
- 7.5.3 PacBio Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.5.4 PacBio Long-Read Sequencing Services Product Portfolio
- 7.5.5 PacBio Recent Developments
- 7.6 Illumina
- 7.6.1 Illumina Company Information
- 7.6.2 Illumina Business Overview
- 7.6.3 Illumina Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Illumina Long-Read Sequencing Services Product Portfolio
- 7.6.5 Illumina Recent Developments
- 7.7 Takara Bio
- 7.7.1 Takara Bio Company Information
- 7.7.2 Takara Bio Business Overview
- 7.7.3 Takara Bio Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Takara Bio Long-Read Sequencing Services Product Portfolio
- 7.7.5 Takara Bio Recent Developments
- 7.8 10X Genomics
- 7.8.1 10X Genomics Company Information
- 7.8.2 10X Genomics Business Overview
- 7.8.3 10X Genomics Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.8.4 10X Genomics Long-Read Sequencing Services Product Portfolio
- 7.8.5 10X Genomics Recent Developments
- 7.9 Danaher
- 7.9.1 Danaher Company Information
- 7.9.2 Danaher Business Overview
- 7.9.3 Danaher Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Danaher Long-Read Sequencing Services Product Portfolio
- 7.9.5 Danaher Recent Developments
- 7.10 Azenta US
- 7.10.1 Azenta US Company Information
- 7.10.2 Azenta US Business Overview
- 7.10.3 Azenta US Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Azenta US Long-Read Sequencing Services Product Portfolio
- 7.10.5 Azenta US Recent Developments
- 7.11 Revvity
- 7.11.1 Revvity Company Information
- 7.11.2 Revvity Business Overview
- 7.11.3 Revvity Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Revvity Long-Read Sequencing Services Product Portfolio
- 7.11.5 Revvity Recent Developments
- 7.12 New England Biolabs
- 7.12.1 New England Biolabs Company Information
- 7.12.2 New England Biolabs Business Overview
- 7.12.3 New England Biolabs Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.12.4 New England Biolabs Long-Read Sequencing Services Product Portfolio
- 7.12.5 New England Biolabs Recent Developments
- 7.13 BaseClear
- 7.13.1 BaseClear Company Information
- 7.13.2 BaseClear Business Overview
- 7.13.3 BaseClear Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.13.4 BaseClear Long-Read Sequencing Services Product Portfolio
- 7.13.5 BaseClear Recent Developments
- 7.14 Element Biosciences
- 7.14.1 Element Biosciences Company Information
- 7.14.2 Element Biosciences Business Overview
- 7.14.3 Element Biosciences Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Element Biosciences Long-Read Sequencing Services Product Portfolio
- 7.14.5 Element Biosciences Recent Developments
- 7.15 CD Genomics
- 7.15.1 CD Genomics Company Information
- 7.15.2 CD Genomics Business Overview
- 7.15.3 CD Genomics Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.15.4 CD Genomics Long-Read Sequencing Services Product Portfolio
- 7.15.5 CD Genomics Recent Developments
- 7.16 Sage Sciences
- 7.16.1 Sage Sciences Company Information
- 7.16.2 Sage Sciences Business Overview
- 7.16.3 Sage Sciences Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.16.4 Sage Sciences Long-Read Sequencing Services Product Portfolio
- 7.16.5 Sage Sciences Recent Developments
- 7.17 EdenRoc Sciences
- 7.17.1 EdenRoc Sciences Company Information
- 7.17.2 EdenRoc Sciences Business Overview
- 7.17.3 EdenRoc Sciences Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.17.4 EdenRoc Sciences Long-Read Sequencing Services Product Portfolio
- 7.17.5 EdenRoc Sciences Recent Developments
- 7.18 Genewiz
- 7.18.1 Genewiz Company Information
- 7.18.2 Genewiz Business Overview
- 7.18.3 Genewiz Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.18.4 Genewiz Long-Read Sequencing Services Product Portfolio
- 7.18.5 Genewiz Recent Developments
- 7.19 BGI Group
- 7.19.1 BGI Group Company Information
- 7.19.2 BGI Group Business Overview
- 7.19.3 BGI Group Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.19.4 BGI Group Long-Read Sequencing Services Product Portfolio
- 7.19.5 BGI Group Recent Developments
- 7.20 Novogene
- 7.20.1 Novogene Company Information
- 7.20.2 Novogene Business Overview
- 7.20.3 Novogene Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.20.4 Novogene Long-Read Sequencing Services Product Portfolio
- 7.20.5 Novogene Recent Developments
- 7.21 Grandomics
- 7.21.1 Grandomics Company Information
- 7.21.2 Grandomics Business Overview
- 7.21.3 Grandomics Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.21.4 Grandomics Long-Read Sequencing Services Product Portfolio
- 7.21.5 Grandomics Recent Developments
- 7.22 Wuhan Beina Technology
- 7.22.1 Wuhan Beina Technology Company Information
- 7.22.2 Wuhan Beina Technology Business Overview
- 7.22.3 Wuhan Beina Technology Long-Read Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.22.4 Wuhan Beina Technology Long-Read Sequencing Services Product Portfolio
- 7.22.5 Wuhan Beina Technology Recent Developments
8 North America
- 8.1 North America Long-Read Sequencing Services Revenue (2021-2032)
- 8.2 North America Long-Read Sequencing Services Revenue by Type (2021-2032)
- 8.2.1 North America Long-Read Sequencing Services Revenue by Type (2021-2026)
- 8.2.2 North America Long-Read Sequencing Services Revenue by Type (2027-2032)
- 8.3 North America Long-Read Sequencing Services Revenue Share by Type (2021-2032)
- 8.4 North America Long-Read Sequencing Services Revenue by Application (2021-2032)
- 8.4.1 North America Long-Read Sequencing Services Revenue by Application (2021-2026)
- 8.4.2 North America Long-Read Sequencing Services Revenue by Application (2027-2032)
- 8.5 North America Long-Read Sequencing Services Revenue Share by Application (2021-2032)
- 8.6 North America Long-Read Sequencing Services Revenue by Country
- 8.6.1 North America Long-Read Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Long-Read Sequencing Services Revenue by Country (2021-2026)
- 8.6.3 North America Long-Read Sequencing Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Long-Read Sequencing Services Revenue (2021-2032)
- 9.2 Europe Long-Read Sequencing Services Revenue by Type (2021-2032)
- 9.2.1 Europe Long-Read Sequencing Services Revenue by Type (2021-2026)
- 9.2.2 Europe Long-Read Sequencing Services Revenue by Type (2027-2032)
- 9.3 Europe Long-Read Sequencing Services Revenue Share by Type (2021-2032)
- 9.4 Europe Long-Read Sequencing Services Revenue by Application (2021-2032)
- 9.4.1 Europe Long-Read Sequencing Services Revenue by Application (2021-2026)
- 9.4.2 Europe Long-Read Sequencing Services Revenue by Application (2027-2032)
- 9.5 Europe Long-Read Sequencing Services Revenue Share by Application (2021-2032)
- 9.6 Europe Long-Read Sequencing Services Revenue by Country
- 9.6.1 Europe Long-Read Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Long-Read Sequencing Services Revenue by Country (2021-2026)
- 9.6.3 Europe Long-Read Sequencing Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Long-Read Sequencing Services Revenue (2021-2032)
- 10.2 China Long-Read Sequencing Services Revenue by Type (2021-2032)
- 10.2.1 China Long-Read Sequencing Services Revenue by Type (2021-2026)
- 10.2.2 China Long-Read Sequencing Services Revenue by Type (2027-2032)
- 10.3 China Long-Read Sequencing Services Revenue Share by Type (2021-2032)
- 10.4 China Long-Read Sequencing Services Revenue by Application (2021-2032)
- 10.4.1 China Long-Read Sequencing Services Revenue by Application (2021-2026)
- 10.4.2 China Long-Read Sequencing Services Revenue by Application (2027-2032)
- 10.5 China Long-Read Sequencing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Long-Read Sequencing Services Revenue (2021-2032)
- 11.2 Asia Long-Read Sequencing Services Revenue by Type (2021-2032)
- 11.2.1 Asia Long-Read Sequencing Services Revenue by Type (2021-2026)
- 11.2.2 Asia Long-Read Sequencing Services Revenue by Type (2027-2032)
- 11.3 Asia Long-Read Sequencing Services Revenue Share by Type (2021-2032)
- 11.4 Asia Long-Read Sequencing Services Revenue by Application (2021-2032)
- 11.4.1 Asia Long-Read Sequencing Services Revenue by Application (2021-2026)
- 11.4.2 Asia Long-Read Sequencing Services Revenue by Application (2027-2032)
- 11.5 Asia Long-Read Sequencing Services Revenue Share by Application (2021-2032)
- 11.6 Asia Long-Read Sequencing Services Revenue by Country
- 11.6.1 Asia Long-Read Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Long-Read Sequencing Services Revenue by Country (2021-2026)
- 11.6.3 Asia Long-Read Sequencing Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Long-Read Sequencing Services Revenue (2021-2032)
- 12.2 SAMEA Long-Read Sequencing Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Long-Read Sequencing Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Long-Read Sequencing Services Revenue by Type (2027-2032)
- 12.3 SAMEA Long-Read Sequencing Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Long-Read Sequencing Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Long-Read Sequencing Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Long-Read Sequencing Services Revenue by Application (2027-2032)
- 12.5 SAMEA Long-Read Sequencing Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Long-Read Sequencing Services Revenue by Country
- 12.6.1 SAMEA Long-Read Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Long-Read Sequencing Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Long-Read Sequencing Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst